What insurance policy changes affect CPT 92082?

There are 8 tracked policy changes affecting CPT 92082, including updates from Aetna Better Health of Virginia, Mississippi Medicaid (DOM), Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 92082?

Payers that have issued tracked updates for CPT 92082 include: Aetna Better Health of Virginia, Mississippi Medicaid (DOM), Aetna, Alaska Medicaid.

How do I get notified when CPT 92082 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 92082. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 92082?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

92082 — A more thorough eye exam that tests a wider area of your side vision to check for blind spots or vision problems.: Insurance Policy Changes

92082 Insurance Policy Changes

CPT 92082, in plain terms, covers A more thorough eye exam that tests a wider area of your side vision to check for blind spots or vision problems. CPT 92082 is referenced in 8 tracked payer policy changes from Aetna Better Health of Virginia, Mississippi Medicaid (DOM), and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 92082 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Medium impact

Venous Stenting for the Treatment of Idiopathic Intracranial Hypertension (CPB 1039, reviewed 2026-01-14)

Aetna·Effective Jan 14, 2026

Aetna has updated its medical policy (CPB 1039) to establish coverage criteria for venous stenting in the transverse sinus for treatment of medically refractory idiopathic intracranial hypertension (IIH). The policy specifies 10 strict medical necessity criteria that must be met for coverage of CPT 61635, and explicitly excludes intravascular ultrasound (CPT 37252, 37253) as experimental. Billing teams must implement prior authorization requirements and ensure all documentation criteria are present before claim submission.

92082 Insurance Policy Changes

Provider Notification - E&M Ophthalmology - Error Fix for Denied Claims

Marketplace Policies and Medicaid Coverage

Special Enrollment Period for Managed Care Members

Pharmacy POS processing server upgrade

Dental replacement codes in effect

Simplified Claims Adjustment Reporting on RA

Venous Stenting for the Treatment of Idiopathic Intracranial Hypertension (CPB 1039, reviewed 2026-01-14)

Vision Exam Limit Clarification